Pacer Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,893
Closed -$993K 2656
2023
Q2
$993K Buy
18,893
+11,994
+174% +$730K ﹤0.01% 1076
2023
Q1
$441K Sell
6,899
-4,220
-38% -$275K ﹤0.01% 1175
2022
Q4
$540K Buy
11,119
+4,718
+74% +$296K ﹤0.01% 1196
2022
Q3
$452K Buy
6,401
+5,562
+663% +$476K ﹤0.01% 848
2022
Q2
$60K Sell
839
-3,057
-78% -$197K ﹤0.01% 2086
2022
Q1
$311K Sell
3,896
-3,172
-45% -$236K ﹤0.01% 1949
2021
Q4
$645K Buy
7,068
+191
+3% +$20.5K 0.01% 1434
2021
Q3
$884K Buy
6,877
+1,830
+36% +$256K 0.01% 929
2021
Q2
$770K Sell
5,047
-127
-2% -$16.7K 0.01% 959
2021
Q1
$545K Buy
+5,174
New +$518K 0.01% 1016

Other funds holding STAA

Pacer Advisors's STAA Position: Q3 2023 in Review

Pacer Advisors sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 18,893 shares — an estimated $993K sold.

Pacer Advisors first reported a position in STAA in Q1 2021 and held it in 10 quarters. The position peaked at $993K in Q2 2023. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

  • Pacer Advisors reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
  • Pacer Advisors sold 18,893 STAAR Surgical shares in Q3 2023, an estimated $993K.
  • Pacer Advisors first reported a position in STAAR Surgical in Q1 2021 and held it in 10 quarters.
  • Pacer Advisors's STAAR Surgical position peaked at $993K in Q2 2023.
  • 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on Pacer Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.